12,372 trials
Influenza
Primary: the Serum Antihemagglutinin Antibody Titers and the Derived Parameters Defined in the Committee for Medicinal Products for Human Use (CHMP) Note for Guidance on…
Scleroderma · Raynaud's Syndrome
Primary: Change in Digital Blood Flow From Pre- to Post-injection. — -36.19; -6.10 Blood flow, measured in LDI flux units,
B-Cell Chronic Lymphocytic Leukemia
Primary: Kaplan-Meier Estimate of Progression Free Survival (PFS) — 30.8; 23.0 months — p=0.323
Frail Elderly · Vitamin d Deficiency
Primary: Change in Short Physical Performance Battery Test Score — 7.3; 7.0 units on a scale
Diabetes Mellitus, Type 2
Primary: Overview of Adverse Event Profile (Treatment Emergent Adverse Events) of the One-Step and Two-Step Titration Arms Assessed Through Adverse Events Collection and Vital…
Actinic Keratosis
Primary: Overall Patient Complete Response 12 Weeks After the Last Photodynamic Therapy (PDT) — 90.9; 21.9 percentage of participants
Hypertension
Primary: Change From Baseline to Week 6 in Trough Clinic Sitting Systolic Blood Pressure (SBP) — -8.776; -22.093; -23.731 mmHg — p=<0.001
Hyponatremia
Primary: Hospital Acquired Hyponatremia — 10; 11; 1 participants
Cocaine Dependence
Primary: Cocaine Urine Toxicology
Behcet's Disease · Behcet Syndrome · Neuro-Behcet's Disease
Primary: Percentage of Participants With Complete Response at Week 30 — 54.5; 0; 100; 100 percentage of Complete Responders
Diabetes Mellitus, Type 2
Primary: Absolute Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24 — -0.38; -0.87; -0.75 percentage of hemoglobin — p=<0.0001
Clostridium Difficile Infection
Primary: Percentage of Participants With Clostridium Difficile Infection (CDI) Recurrence — 25.9; 17.4; 15.9; 27.6 Percentage of participants — p=0.3182
Age-related Macular Degeneration · Choroidal Neovascularization
Primary: Change in Best Corrected Visual Acuity (BCVA) From Baseline to Month 12 — 6.2; 8.1 Letters (EDTRS) — p=<0.001
Asthma
Primary: Number of Participants Experiencing an Event in the Composite Endpoint (Asthma-related Death, Asthma-related Intubation or Asthma-related Hospitalization) — 43; 40…
Rheumatoid Arthritis
Primary: Change From Baseline in Clinical Disease Activity Index (CDAI) at Week 24 — -21.6 units on a scale — p=<0.0001